throbber
HEALTHCARE
`
`PURCHASING NEWS
`
`July 2008
`The self-study lesson on this central service topic was
`developed by STERIS. The lessons are administered by
`KSR Publishing, Inc.
`
`Earn CEUs
`The series can assist readers in maintaining their CS
`certification. After careful study of the lesson, complete
`the examination at the end of this section. Mail the
`complete examination and scoring fee to Healthcare
`Purchasing News for grading. We will notify you if you
`have a passing score of 70 percent or higher, and you
`will receive a certificate of completion within 30 days.
`Previous lessons are available on the Internet at
`wwwhpnonline.com
`
`Certification
`The CBS PD ( Certification Board for Sterile Processing
`and Distribution) has pre-approved this in-service for
`one (1) contact hour for a period of five (5) years from
`the date of original publication. Successful completion
`of the lesson and post test must be documented by
`facility management and those records maintained by
`the individual until re-certification is required. DO NOT
`SEND LESSON OR TEST TO CBSPD.
`
`For additional information regarding certification con(cid:173)
`tact CBS PD - 2 Industrial Park Road, Suite 3, Alpha, NJ
`08865. For more information Direct any questions to
`Healthcare Purchasing Ne'NS (941) 927-9345, ext 202.
`
`Leaming
`Objectives
`1. Compare the uses of various
`low-temperature sterilization
`processes for packaged devices
`
`2. Discuss the newest healthcare
`technology - vaporized hydrogen
`peroxide (VHP) - and its history
`and various applications
`
`3. Understand the benefits and
`drawbacks of available low(cid:173)
`temperature sterilization systems
`in order to make educated decisions
`for the readers' facilities
`
`Sponsored by:
`
`ST ~ I s·
`::-::: -
`
`and
`
`STER I s·
`
`Sponsored by
`
`SELf-STUDY SERIES
`The lowdown on low
`temperature sterilization for
`packaged devices
`
`by Pamela Carter, RN, BSN, CNOR, and Michael Wright
`
`W ith so many surgeries, so many
`
`delicate instruments, so many
`sterilization options and so
`little time, even the most seasoned sterile
`processing manager's head can be left
`spinning. The intent of this self study
`guide is to improve your understanding
`of the available low-temperature steriliza(cid:173)
`tion technologies for packaged devices
`(including a very new low-temperature
`alternative) by comparing their capabili(cid:173)
`ties and challenges. Once armed with this
`information, you can potentially simplify
`your processing and equipment decisions.
`With so many low-temperature sterilizers
`to choose from, how can you narrow down your
`choices?
`All the systems and methods we will
`discuss here are FDA cleared technologies,
`so they are all effective at sterilizing pack(cid:173)
`aged devices. Each modality, however,
`has its own costs and benefits, and should
`be weighed based on the goals of your
`sterile processing department Unfortu(cid:173)
`nately, there is no "silver bullet" that pro(cid:173)
`vides the perfect combination of a fast
`cycle time and a broad range of material
`compatibility. According to the Interna(cid:173)
`tional Association of Healthcare Central
`Service Materiel Management, sterile pro(cid:173)
`cessing professionals must consider eight
`basic requirements when evaluating low(cid:173)
`temperature sterilization systems; effec(cid:173)
`tiveness, safety, monitoring, quality
`assurance, sterilant penetration, material
`compatibility, adaptability and approval.
`In this self-study article, we will briefly
`discuss the sterilization parameters and
`special requirements for sterilization, and
`compare the "pros" and "cons" of each
`technology.
`
`A day in the life of a packaged
`device
`Sterile processing departments (SPDs)
`must process heat- and moisture-sensitive
`instruments for same-day, next-day and
`emergency uses. They typically sterilize
`
`packaged delicate medical devices during
`the day for re-use later in the daily sched(cid:173)
`ule, and at the end of each day, to store in
`preparation for the first surgical cases
`scheduled the following morning. They
`also proactively sterilize packaged sets
`and devices that can wait in sterile stor(cid:173)
`age for unplanned emergencies. Until
`2008, there were three options for these
`purposes; ethylene oxide (EO), gas
`plasma, and ozone systems.
`
`EO gas sterilization
`Ethylene oxide was first used in the 1950s
`to sterilize heat and moisture-sensitive
`medical devices. Today, EO systems are
`manufactured by 3M and STERIS Corpo(cid:173)
`ration, among others. EO is a colorless gas
`that readily and rapidly permeates medi(cid:173)
`cal devices, and is sporicidal and non-cor(cid:173)
`rosive. However, it is also flammable and
`combustible at high concentrations and
`high volumes. Today, 100% EO is used as
`an alternative to the blended mixtures as
`it does not contain environmentally haz(cid:173)
`ardous compounds (hydrochloroflouro(cid:173)
`carbons or HCFCs) . 100% EO does not
`contribute to ozone depletion.
`EO is a reactive chemical that is an alky(cid:173)
`lating agent It contacts molecules in the
`presence of moisture, altering their size
`and shape. As a result, the molecules be(cid:173)
`come unable to perform necessary func(cid:173)
`tions, and this leads to the organism's
`death. 1
`Sterilization parameters: The important
`variables that ensure efficient sterilization
`with EO are time, temperature, EO con(cid:173)
`centration, and a relative humidity of at
`least 35 to 85%. These variables are con(cid:173)
`trolled during the sterilization process in
`the conditioning, sterilization and aera(cid:173)
`tion phases of an automated system.
`Special requirements: Effective Decem(cid:173)
`ber 29, 2008, 2 the new record-keeping by
`Environmental Protection Agency stan(cid:173)
`dards requires that hospitals without an
`air pollution control device (catalytic con-
`
`42 July 2008 · HEALTHCARE PURCHASING NEWS
`
`· www.hpnonline.com
`
`Regeneron Exhibit 1046.001
`
`

`

`verter or acid-water scrubber) record that
`a full load was run and if not, provide a
`statement indicating that it was "medi(cid:173)
`cally necessary" (air pollution control
`equipment reduces the quantity of EO
`from sterilization and aeration processes).
`In addition, aeration of toxic EO is re(cid:173)
`quired to remove it from instruments and
`devices for use or storage; environmental
`and personnel monitoring (equipment
`and badges) is required to determine the
`level of EO exposure; and record-keeping
`of each cycle is required.
`Pros of EO: Ethylene oxide sterilization
`offers superior penetration and compat(cid:173)
`ibility for devices including flexible
`endoscopes, has no lumen restrictions and
`no packaging restrictions, and offers
`broad compatibility with device compo(cid:173)
`nent and other materials.
`Cons of EO: The process requires pro(cid:173)
`longed, lengthy aeration cycles, environ(cid:173)
`mental and personnel monitoring, and a
`new record-keeping protocol per EPA; the
`cost of EO blend mixtures is high, there
`are specific installation requirements, and
`EO is toxic and flammable.
`
`to 75 minutes. Cycle times are dependent
`upon model type, device design, materi(cid:173)
`als types and load size.
`Special requirements: None.
`Pros of gas plasma: Gas plasma systems
`have rapid cycle times, and require no
`aeration and no personnel monitors. They
`have non-toxic by-products (water and
`oxygen) and are compatible with a wide
`variety of materials and devices includ(cid:173)
`ing limited single-channel flexible surgi(cid:173)
`cal scopes, instruments processed with
`gas plasma have a long shelf life, and the
`H202 sterilant cassette is self-contained.
`Cons of gas plasma: The process is ex(cid:173)
`tremely moisture-sensitive (the cycle may
`abort if excess moisture is present), cer(cid:173)
`tain models have limited capacity, and
`specific flexible scope materials may not
`be compatible with the process. High H202
`concentrations (up to 95% on certain mod(cid:173)
`els) are necessary, and there are special
`loading considerations (avoid contact
`with chamber walls, not too many metal
`instruments) due to the plasma coil. The
`process also has some penetration limita(cid:173)
`tions (follow lumen diameter and length
`guidelines). In addition, mechanical prob(cid:173)
`lems have been documented that can lead
`to H202 residuals within the load or the
`release of H202 from the chamber.1
`
`Gas plasma sterilization
`The gas plasma process has been in exist(cid:173)
`ence since the early 1990s and has become
`popular due to its short cycle times, which
`Ozone sterilization
`facilitate faster instrument turnaround.
`Low-temperature hydrogen peroxide gas
`Ozone is an effective low temperature
`plasma sterilization uses a combination of
`sterilization method. It requires no ster(cid:173)
`ilant purchase because the system itself
`hydrogen peroxide vapor and plasma.
`generates 0 3 using only water and oxy(cid:173)
`Hydrogen peroxide vapor is generated
`from 59% liquid peroxide. Some systems
`gen (this type of sterilizer is available from
`generate a metered dosage at a predeter(cid:173)
`TS03, Inc.). Ozone is diffused through the
`
`mined volume onto a heated vaporizer
`load by a vacuum/humidification process
`and introduce it into the sterilization
`and organisms are killed by oxidation,
`chamber, while others use a single-unit
`which attacks an organism's structure and
`dose cartridge that is punctured and
`makes it non-viable. At the end of each
`pulled into the evacuated chamber dur(cid:173)
`cycle, ozone is exhausted through a cata(cid:173)
`ing the sterilization process (this process
`lytic converter. The total cycle time is 4 to
`is used in STERRAD® sterilizers). Some of
`5 hours.
`these systems condense water from the
`Sterilization parameters: The key vari(cid:173)
`sterilant, which results in a hydrogen per(cid:173)
`ables for sterilization are time, tempera(cid:173)
`ture, 0 3 concentration, relative humidity
`oxide concentration of approximately
`95% (please see sidebar). At the comple(cid:173)
`of at least 85 to 100% to precondition the
`tion of the cycle, the by-products are va(cid:173)
`load, and a sterilization temperature
`porized water and oxygen.
`maintained at 30 to 36 degrees Celsius.
`Sterilization parameters: The important
`Approximately 700 to 800 liters of oxygen
`variables that ensure sterilization are time,
`and few milliliters of water are used dur(cid:173)
`temperature, H 202 concentration, and
`ing the processing.
`Special requirements: Systems require
`vacuum level. The process phases include
`a leak test, conditioning, sterilization and
`medical grade oxygen and deionized
`aeration, with a cycle time variance of 28
`water.
`3 ·o~ '!) '6 'a '8 '3 'L '3 ·9 'V ·s 'a ·17 'a 'E '3 ·z 'V -~
`
`Sponsored by STER I S SELf-STLJDY SERIES
`
`Pros of ozone: Cycles are inexpensive
`and there is no sterilant to handle. No
`venting or personnel monitors are re(cid:173)
`quired, and the systems produce non(cid:173)
`toxic by-products and have a large
`processing capacity.
`Cons of ozone: The cycles are long and
`there are some penetration limitations
`(you must follow lumen diameter and
`length guidelines). There are safety and
`ergonomic concerns because of the large
`oxygen tanks supplying the system. In ad(cid:173)
`dition, ozone processes have no flexible
`scope sterilization claim, and not all de(cid:173)
`vice and packaging materials are compat(cid:173)
`ible with the process.
`
`New kid on the sterile
`processing block - VHP
`sterilization
`Vaporized hydrogen peroxide (VHP) technol(cid:173)
`ogy was originally developed by STERIS
`Corporation and introduced in the early
`1990s. It soon became a "gold standard"
`for pharmaceutical sterilization, in criti(cid:173)
`cal environments where drugs are pro(cid:173)
`duced and packaged. The applications of
`VHP have extended beyond pharmaceu(cid:173)
`tical production to include the steriliza(cid:173)
`tion of medical devices and room surfaces
`(research labs, etc.). More recently, the
`technology has been used to decontami(cid:173)
`nate entire buildings. During the anthrax
`attacks in the United States in 2002, VHP
`played an integral part in the clean-up
`effort. The systems were used to fumigate
`areas contaminated with the toxin. It was
`also used after the flood waters of Hurri(cid:173)
`cane Katrina receded in New Orleans and
`in hospitals abroad, to limit MRSA out(cid:173)
`breaks. Two new VHP systems have been
`introduced within the last 1 1/2 years for
`use in healthcare facilities; one for room
`sterilization and one for processing pack(cid:173)
`aged, heat and moisture-sensitive instru(cid:173)
`ments for terminal sterilization and
`storage.
`VHP is created by dropping liquid hy(cid:173)
`drogen peroxide onto a hot surface, in(cid:173)
`stantaneously transforming it into a dry
`vapor form. VHP is extremely effective
`as an antimicrobial (bactericidal, fungi(cid:173)
`cidal, virucidal and sporicidal) agent. In
`contrast, liquid H 202 requires a much
`higher concentration (370mg/L) than
`gaseous Hp2 (1-2mg/L) to achieve the
`same 1-log reduction of living organisms
`See SELF-STUDY on page 44
`
`:sJaMSUV isau1as
`
`www.hpnonline.com • HEALTHCARE PURCHASING NEWS · July 2008 43
`
`Regeneron Exhibit 1046.002
`
`

`

`SELf-STUDY SERIES
`
`Sponsored by
`
`STER Is·
`
`59%
`Hydrogen
`Peroxide
`(Liquid)
`
`Hydrogen
`Peroxide
`(vapor)
`
`H
`
`0
`
`0
`
`H
`
`Vaporization
`
`Bactericidal, virucidal,
`fungicidal and sporicidal at
`low concentrations
`
`H 0
`
`H
`
`+
`
`0
`
`0
`
`Water and
`oxygen
`
`Self-Study from page 43
`(D-value). Since VHP is injected under
`vacuum conditions to sterilize devices,
`the vapor easily permeates the packag(cid:173)
`ing and the load, contacting all surfaces
`and penetrating hard-to-reach lumens.
`The newest VHP-based low-temperature
`sterilization system (V-PRO'M 1 Low
`Temperature Sterilization System) offers
`a more productive, less process-sensitive
`alternative to EO, gas plasma, and ozone
`systems.
`This system's VHP automated cycle is
`20 minutes faster than some gas plasma
`cycles, three to four hours faster than the
`ozone process, and so much faster than
`the EO process that up to 16 additional
`loads can be processed each day.
`Aborted cycles have become a chal(cid:173)
`lenge for the SPD because they result in
`repackaging, reloading and reprocess(cid:173)
`ing of the devices, and they cost the de(cid:173)
`partment in additional sterilant and
`staff time. Aborted cycles can also im(cid:173)
`pact surgical suite productivity in the
`form of delayed or cancelled procedures
`and a disrupted OR schedule. Aborted
`cycles can often be an issue with gas
`plasma systems, which are highly sen(cid:173)
`sitive to the way in which contents are
`loaded into the chamber, to residual
`moisture on the instruments, and to the
`amount of metal contained in the instru(cid:173)
`ment packs. Any of these factors may
`cause unnecessary cycle aborts. In con(cid:173)
`trast, the VHP sterilization process is not
`hypersensitive to load contents and po(cid:173)
`sitioning, and the cycle includes a pre(cid:173)
`conditioning phase that automatically
`detects and removes excess moisture,
`which helps to alleviate aborted cycles
`and their frustrating consequences.
`
`Sterilization parameters: Important
`variables to ensure sterilization are time,
`temperature, H 202 concentration and
`vacuum level. The process phases include
`conditioning, sterilization and aeration for
`a short cycle time (55 minutes).
`Special requirements: None
`Pros of VHP: The system offers a rapid
`cycle time and a larger processing capac(cid:173)
`ity than other systems. No plasma is nec(cid:173)
`essary for this process. A pre-conditioning
`phase detects and removes excess mois(cid:173)
`ture, and no aeration or personnel moni(cid:173)
`tors are required. The by-products of the
`process are non-toxic (water and oxygen),
`and the process is compatible with many
`devices. Instrumentation processed with
`VHP has a long shelf life, and the sterilant
`is generated from a closed H202 (Vaprox®)
`cartridge.
`Cons of VHP: There are penetration limi(cid:173)
`tations that require adherence to the
`system's lumen diameter and length guide(cid:173)
`lines, and the VHP process has no flexible
`scope sterilization claim. In addition, VHP
`should not be used to sterilize cellulose ma(cid:173)
`terials (disposable towels, paper, etc.).
`
`Select the best processes and
`systems for your needs
`In a busy SPD, even modest improve(cid:173)
`ments to processing volume and time can
`make a huge difference in the depart(cid:173)
`ment's productivity each day. Specifi(cid:173)
`cally, variables such as cycle time and
`aborted cycles can affect the total number
`of loads that can be successfully sterilized
`each day, so both should be reduced as
`much as possible.
`Patient and staff safety is another criti(cid:173)
`cal factor to consider when selecting ster(cid:173)
`ilizers. If exposure to potentially harmful
`
`44 July 2008 · HEALTHCARE PURCHASING NEWS
`
`· www.hpnonline.com
`
`agents can be minimized or avoided, the
`risks to the facility and its occupants can
`be reduced as well. At the same time, the
`facility must have technologies in place
`that provide them with the capability to
`process every material and device they re(cid:173)
`use, since contaminated instruments also
`pose a risk to patients.
`Achieving effective, safe and productive
`sterilization of packaged heat-sensitive re(cid:173)
`usable devices requires a balancing act.
`Sterile processing decision-makers should
`consider the sterilization options available
`in the marketplace and combine them in
`a way that best meets their hospital's cur(cid:173)
`rent and future needs. HPN
`
`Pamela Carter, RN, BSN, CNOR is a clinical
`education specialist with STERZS Corporation.
`Michael Wright is a product manager for
`STERZS.
`
`STERRAD® is a registered trademark of Advanced Sterilization
`Products, a Johnson & Johnson company.
`
`Vaprox® and V-PRO'~ are registered trademarks of STERIS Corpo(cid:173)
`ration.
`
`References
`
`1. Central Service Technical Manual, 7111 Edition, IAHCSMM.
`
`2. Federal Register/Vol. 72, No.248/Friday, December 28,
`2007 /Rules and Regulations, Environmental Protection Agency.
`40 CFR Part 63: National Emission Standards for Hospital Eth(cid:173)
`ylene Oxide Sterilizers. Accessed: http:f / www.epa.gov/EPA(cid:173)
`AI R/2007 /December/Day-28/ a2 52 33. pdf
`
`3. Standards, Recommended Practices, and Guidelines, 2008,
`AORN, Denver, p. 581-585.
`
`4. McDonnell, GE, Antisepsis, Disinfection, and Sterilization,
`Types, Action, and Resistance, 2007, ASM Press; W ashing(cid:173)
`ton, DC.
`
`5. Reichert, M. and Young J., Sterilization Technology for the
`Health Care Facility, 1993, Aspen Publishers, Inc.,
`Gaithersburg, MD.
`
`Benefits of hydrogen peroxide
`Chances are you have a brown bottle of 3%
`hydrogen peroxide (H 20) in your medicine cabi(cid:173)
`net at home to clean scrapes or wounds. Be(cid:173)
`sides its traditional use as an antiseptic, H202
`has also been used in various applications
`around the world as a preservative, disinfec(cid:173)
`tant, fumigant and sterilant. While it is a strong
`oxidizing agent, it has very effective antimi(cid:173)
`crobial activity without being overly aggressive
`on surfaces. In its normal form at room tem(cid:173)
`perature, it's a colorless, odorless and stable
`liquid usually provided at concentrations less
`than 60%. It is available in concentrations from
`3% to 90%, but at concentrations above 60%
`it's considered to be more reactive and un(cid:173)
`stable, and may pose a health hazard. HA is
`environmentally friendly, since it breaks down
`into water and oxygen very easily.
`
`Regeneron Exhibit 1046.003
`
`

`

`CONTINUING EDUCATION TEST • JULY 2008
`
`The lowdown on low temperature sterilization
`for packaged devices
`
`1. VHP technology has been in existence for
`nearly 20 years and used in a variety of
`applications, including the sterilization of
`packaged medical devices and room
`surfaces.
`a. True
`b. False
`
`2. Which of the following parameters must
`be met to achieve sterilization using VHP
`technology?
`a. Time
`b. Temperature
`c. Vacuum
`d. Hydrogen peroxide concentration
`e. All of the above
`
`3. Which of the following factor(s)
`increase(s) the chance for an aborted
`cycle in gas plasma processes?
`a. Loading the chamber - contact with
`sterilizer walls
`b. Residual moisture on instruments
`c. The amount of metal contained in
`instrument packs
`d. All of the above
`
`Circle the one correct answer:
`
`4. VHP uses alkylation to deactivate harmful
`microorganisms.
`a. True
`b. False
`
`8. A large volume of hydrogen peroxide is
`necessary to create VHP.
`a. True
`b. False
`
`5. The EPA has mandated that all EO sterilizers
`must use an air pollution control device or
`document all loads.
`a. True
`b. False
`
`6. The benefits of EO sterilization include:
`a. No lumen restrictions
`b. Superior Sterilant penetration
`c. Flexible endoscope compatibility
`d. No monitoring required
`e. a, band c
`f. All of the above
`
`7. Which of the following is required for ozone
`sterilization?
`a. Oxygen
`b. Water
`C. Hydrogen Peroxide
`d. Nitrogen
`e. a and b
`f. c and d
`g. a and c
`
`9. Which of the following is the greatest benefit
`of EO sterilization?
`a. Cycle Time
`b. Penetration
`c. Material Compatibility
`d. No personnel monitoring
`e. a and b
`f. c and d
`g. band c
`
`10. Which of the following technologies is
`cleared for use in the SPD to sterilize
`packaged devices?
`a. EO
`b. Gas Plasma
`c. Ozone
`d. VHP
`e. All of the above
`
`CONTINUING EDUCATION TEST · JULY 2008
`
`Presented by
`HEALTHCARE
`
`PURCHASING N E W S
`
`Sponsored by
`STER IS"
`= = ~
`
`Request for Scoring
`• I have enclosed the scoring fee
`of $10. (Payable to KSR Publish(cid:173)
`ing, Inc. We regret that no refunds
`can be given. Multiple submissions
`may be paid with a single check.)
`
`Detach exam and return to:
`Continuing Education Division
`KSR Publishing, Inc.
`2477 Stickney Point Road, Suite 315B
`Sarasota, FL 34231
`PH: 941-927-9345 Fax: 941-927-9588
`
`Please print or type. Return this page only.
`Name
`Title
`Hospital Name
`Mailing Address
`Apt/Suite
`City, State, Zip
`Daytime Phone
`E-mail
`
`www.hpnonline.com • HEALTHCARE PURCHASING NEWS · July 2008 45
`
`Regeneron Exhibit 1046.004
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket